Ruchika Talwar1, Adrien Bernstein2, Amanda Jones3, Juanita Crook4, Andrea B Apolo5, Jennifer M Taylor6, Lauren M Burke7, Elizabeth R Plimack8, Sima P Porten9, Kirsten L Greene10, Sarah P Psutka11, Angela B Smith12. 1. Division of Urology, University of Pennsylvania, Philadelphia, PA; Leonard Davis Institute for Health Economics, University of Pennsylvania, Philadelphia, PA. Electronic address: ruchika.talwar@pennmedicine.upenn.edu. 2. Division of Urology, Fox Chase Cancer Center, Philadelphia, PA. 3. Division of Urology, University of Pennsylvania, Philadelphia, PA. 4. BCCA Center for the Southern Interior, University of British Columbia, Kelowna, BC, Canada. 5. Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD. 6. Department of Urology, Baylor College of Medicine, Houston, TX. 7. Department of Radiology, Division of Abdominal Imaging, University of North Carolina, Chapel Hill, NC. 8. Department of Hematology-Oncology, Fox Chase Cancer Center, Philadelphia, PA. 9. Department of Urology, University of California San Francisco, San Francisco, CA. 10. Department of Urology, University of VA, Charlottesville, VA. 11. Department of Urology, University of Washington, Seattle, WA. 12. Department of Urology, University of North Carolina, Chapel Hill, NC.
Abstract
OBJECTIVE: To evaluate multidisciplinary female representation at urologic oncology conferences, we reviewed speakership trends at contemporary Society of Urologic Oncology (SUO) and American Society of Clinical Oncology Genitourinary Symposium (GU-ASCO) annual meetings. METHODS: Meeting programs from SUO and GU-ASCO from 2015 to 2019 were analyzed. Biographical information was determined by querying institutional websites and social/professional media platforms. Statistical analyses were performed to assess for differences and relationships between male and female authorship based on gender, specialty, professional, and educational factors. RESULTS: We identified 1102 speakers at genitourinary oncology conferences. Overall, 222 (20%) were female. There was no significant difference between female speakership rates at SUO and GU-ASCO. The overall proportion of female speakers increased over time, but not when analyzing each individual subspecialty conference separately. Several professional and educational differences were noted between genders. Female speakers were more likely to be medical oncologists (P <.001), have more recent years of graduation (2001 vs 1996, P <.001), hold an additional advanced degree (OR 2.09, P = .005), and speak in sessions where other women served as chair (OR 1.42, P = .044). Conversely, female speakers had lower odds of delivering a plenary or keynote address (OR 0.28, P = .015). CONCLUSION: We identified a significantly positive trend towards increased female representation within contemporary genitourinary conferences over time; these trends did not remain significant when analyzing each meeting separately. Several important disparities between men and women speakers were identified. Our data suggests that inclusion of women in planning committees may help reduce gender bias and promote diversity within urologic oncology.
OBJECTIVE: To evaluate multidisciplinary female representation at urologic oncology conferences, we reviewed speakership trends at contemporary Society of Urologic Oncology (SUO) and American Society of Clinical Oncology Genitourinary Symposium (GU-ASCO) annual meetings. METHODS: Meeting programs from SUO and GU-ASCO from 2015 to 2019 were analyzed. Biographical information was determined by querying institutional websites and social/professional media platforms. Statistical analyses were performed to assess for differences and relationships between male and female authorship based on gender, specialty, professional, and educational factors. RESULTS: We identified 1102 speakers at genitourinary oncology conferences. Overall, 222 (20%) were female. There was no significant difference between female speakership rates at SUO and GU-ASCO. The overall proportion of female speakers increased over time, but not when analyzing each individual subspecialty conference separately. Several professional and educational differences were noted between genders. Female speakers were more likely to be medical oncologists (P <.001), have more recent years of graduation (2001 vs 1996, P <.001), hold an additional advanced degree (OR 2.09, P = .005), and speak in sessions where other women served as chair (OR 1.42, P = .044). Conversely, female speakers had lower odds of delivering a plenary or keynote address (OR 0.28, P = .015). CONCLUSION: We identified a significantly positive trend towards increased female representation within contemporary genitourinary conferences over time; these trends did not remain significant when analyzing each meeting separately. Several important disparities between men and women speakers were identified. Our data suggests that inclusion of women in planning committees may help reduce gender bias and promote diversity within urologic oncology.
Authors: Katherine M Gerull; Brandon Malik Wahba; Laurel M Goldin; Jared McAllister; Andrew Wright; Amalia Cochran; Arghavan Salles Journal: Am J Surg Date: 2019-09-09 Impact factor: 2.565
Authors: Allison R Wilcox; Spencer W Trooboff; Christine S Lai; Patricia L Turner; Sandra L Wong Journal: J Am Coll Surg Date: 2019-06-29 Impact factor: 6.113
Authors: Benjamin N Breyer; Christi Butler; Raymond Fang; William Meeks; Sima P Porten; Amanda C North; Jennifer T Anger Journal: Urology Date: 2020-01-07 Impact factor: 2.649
Authors: Julie A Thompson-Burdine; Dana A Telem; Jennifer F Waljee; Erika A Newman; Dawn M Coleman; Hadley I Stoll; Gurjit Sandhu Journal: JAMA Netw Open Date: 2019-08-02
Authors: J Schroeder; H L Dugdale; R Radersma; M Hinsch; D M Buehler; J Saul; L Porter; A Liker; I De Cauwer; P J Johnson; A W Santure; A S Griffin; E Bolund; L Ross; T J Webb; P G D Feulner; I Winney; M Szulkin; J Komdeur; M A Versteegh; C K Hemelrijk; E I Svensson; H Edwards; M Karlsson; S A West; E L B Barrett; D S Richardson; V van den Brink; J H Wimpenny; S A Ellwood; M Rees; K D Matson; A Charmantier; N Dos Remedios; N A Schneider; C Teplitsky; W F Laurance; R K Butlin; N P C Horrocks Journal: J Evol Biol Date: 2013-06-20 Impact factor: 2.411
Authors: Laura S Graham; Alexandra O Sokolova; Ali Raza Khaki; Qian Vicky Wu; Nancy E Davidson Journal: Cancer Invest Date: 2020-11-11 Impact factor: 2.176